Corrigendum: Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine (Nature Genetics, (2016), 10.1038/ng.3598);Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine

Nature Genetics

Volumn 48, Issue 8, 2016, Pages 856-866

  Gormley, Padhraig ^a,b,c   Anttila, Verneri ^a,b   Winsvold, Bendik S ^d,e   Palta, Priit ^f   Esko, Tonu ^b,g,h   Pers, Tune H ^b,h,i,j   Farh, Kai How ^a,b,k   Cuenca Leon, Ester ^a,b,l   Muona, Mikko ^f,m   Furlotte, Nicholas A ⁿ   Kurth, Tobias ^o,p,ae   Ingason, Andres ^q   McMahon, George ^r   Ligthart, Lannie ^s   Terwindt, Gisela M ^t   Kallela, Mikko ^u   Freilinger, Tobias M ^v,w   Ran, Caroline ^x   Gordon, Scott G ^y   Stam, Anine H ^t   Steinberg, Stacy ^q   Borck, Guntram ^z   Koiranen, Markku ^aa   Quaye, Lydia ^ab   Adams, Hieab H H ^ac   Lehtimäki, Terho ^ad   Sarin, Antti Pekka ^f   Wedenoja, Juho ^f   Hinds, David A ⁿ   Buring, Julie E ^p,ae   Schürks, Markus ^ae,af   Ridker, Paul M ^p,ae   Hrafnsdottir, Maria Gudlaug ^ag   Stefansson, Hreinn ^q   Ring, Susan M ^r   Hottenga, Jouke Jan ^s   Penninx, Brenda W J H ^ah   Färkkilä, Markus ^u   Artto, Ville ^u   Kaunisto, Mari ^f,m   Vepsäläinen, Salli ^u   Malik, Rainer ^w   Heath, Andrew C ^ai   Madden, Pamela A F ^ai   Martin, Nicholas G ^y   Montgomery, Grant W ^y   Kurki, Mitja I ^a,b,f,aj   Kals, Mart ^g   Mägi, Reedik ^g   Pärn, Kalle ^g   Hämäläinen, Eija ^f   Huang, Hailiang ^a,b   Byrnes, Andrea E ^a,b   Franke, Lude ^ak   Huang, Jie ^c   Stergiakouli, Evie ^r   Lee, Phil H ^a,b   Sandor, Cynthia ^al   Webber, Caleb ^al   Cader, Zameel ^al,am   Muller Myhsok, Bertram ^an,bg,bo   Schreiber, Stefan ^ao   Meitinger, Thomas ^ap,aq   Eriksson, Johan G ^f,ar   Salomaa, Veikko ^ar   Heikkilä, Kauko ^f   Loehrer, Elizabeth ^ac,as   Uitterlinden, Andre G ^ac   Hofman, Albert ^ac   van Duijn, Cornelia M ^ac   Cherkas, Lynn ^ab   Pedersen, Linda M ^d   Stubhaug, Audun ^d,at   Nielsen, Christopher S ^d,au   Männikkö, Minna ^aa   Mihailov, Evelin ^g   Milani, Lili ^g   Göbel, Hartmut ^av   Esserlind, Ann Louise ^aw   Christensen, Anne Francke ^aw   Hansen, Thomas Folkmann ^aw,ax   Werge, Thomas ^ax,ay,az   Kaprio, Jaakko ^f,ar   Aromaa, Arpo J ^ar   Raitakari, Olli ^ba,bb,bn   Ikram, M Arfan ^ac   Spector, Tim ^ab   Järvelin, Marjo Riitta ^aa,bc,bd   Metspalu, Andres ^g   Kubisch, Christian ^be   Strachan, David P ^bf   Ferrari, Michel D ^t   Belin, Andrea Carmine ^x   Dichgans, Martin ^w,bg   Wessman, Maija ^f,m   van den Maagdenberg, Arn M J M ^t   Zwart, John Anker ^d,e   Boomsma, Dorret I ^s   Smith, George Davey ^r   Stefansson, Kari ^q,bh   Eriksson, Nicholas ⁿ   Daly, Mark J ^a,b   Neale, Benjamin M ^a,b   Olesen, Jes ^aw   Chasman, Daniel I ^p,ae   Nyholt, Dale R ^bi   Palotie, Aarno ^a,b,c,f   Børte, Sigrid ^d   Cormand, Bru ^bj   Eising, Else ^t   Ferrari, Michel ^t   Frants, Rune R ^t   Griffiths, Lyn ^bi   Hamalainen, Eija ^f   Hiekkala, Marjo ^m   Kajanne, Risto ^f   Kurki, Mitja ^b   Launer, Lenore ^bk   Lessel, Davor ^be   Litterman, Nadia ⁿ   Macaya, Alfons ^l   Mangino, Massimo ^ab   Northover, Carrie ⁿ   Pedersen, Nancy ^x   Posthuma, Danielle ^s   Pozo Rosich, Patricia ^bl,bp   Pressman, Alice ^bm   Sintas, Celia ^bj   Strachan, David ^bf   Vila Pueyo, Marta ^l   Wrenthal, William ^b   Zhao, Huiying ^bi   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UNIVERSITY OF TARTU   (Estonia)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ STATENS SERUM INSTITUT   (Denmark)

^j Capital Region   (Denmark)

^k ILLUMINA INC   (United States)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

ⁿ 23andMe Inc ^*  (United States)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p BRIGHAM AND WOMEN S HOSPITAL   (United States)

^q DECODE GENETICS   (Iceland)

^r UNIVERSITY OF BRISTOL   (United Kingdom)

^s VU UNIVERSITY AMSTERDAM   (Netherlands)

^t LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^u HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^v UNIVERSITY OF TÜBINGEN   (Germany)

^w LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^x KAROLINSKA INSTITUTE   (Sweden)

^y QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^z UNIVERSITY OF ULM   (Germany)

^aa UNIVERSITY OF OULU   (Finland)

^ab KING'S COLLEGE LONDON   (United Kingdom)

^ac ERASMUS MEDICAL CENTER   (Netherlands)

^ad FIMLAB LABORATORIES   (Finland)

^ae HARVARD MEDICAL SCHOOL   (United States)

^af UNIVERSITY HOSPITAL ESSEN   (Germany)

^ag LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^ah VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^ai WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aj KUOPIO UNIVERSITY HOSPITAL   (Finland)

^ak UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^al UNIVERSITY OF OXFORD   (United Kingdom)

^am JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^an MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^ao UNIVERSITY OF KIEL   (Germany)

^ap INSTITUTE OF EPIDEMIOLOGY   (Germany)

^aq TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ar NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^as HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^at UNIVERSITY OF OSLO   (Norway)

^au NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^av Kiel Pain and Headache Centre   (Germany)

^aw Rigshospitalet   (Denmark)

^ax UNIVERSITY OF COPENHAGEN   (Denmark)

^ay Mental Health Services   (Denmark)

^az H LUNDBECK A S   (Denmark)

^ba UNIVERSITY OF TURKU   (Finland)

^bb TURKU UNIVERSITY HOSPITAL   (Finland)

^bc Imperial College London   (United Kingdom)

^bd OULU UNIVERSITY HOSPITAL   (Finland)

^be UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^bf ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^bg Germany 3 Munich Cluster for Systems Neurology   (Germany)

^bh UNIVERSITY OF ICELAND   (Iceland)

^bi QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^bj UNIVERSITY OF BARCELONA   (Spain)

^bk NATIONAL INSTITUTE ON AGING   (United States)

^bl UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^bm SUTTER HEALTH   (United States)

^bn UNIVERSITY OF TURKU   (Finland)

^bo UNIVERSITY OF LIVERPOOL   (United Kingdom)

^bp HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIGRAINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR SMOOTH MUSCLE; X CHROMOSOME; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; METABOLISM; SMOOTH MUSCLE; VASCULAR DISEASE;

GENETIC MARKER;

CASE-CONTROL STUDIES; GENETIC LOCI; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; MIGRAINE DISORDERS; MUSCLE, SMOOTH; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR DISEASES;

EID: 84975318713     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1016-1296c     Document Type: Erratum

References (91)

1. Vos, T. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163-2196 (2012)
2. Vos, T. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 743-800 (2015)
3. Gustavsson, A. et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21, 718-779 (2011)
4. Pietrobon, D. &Striessnig, J. Neurological diseases: neurobiology of migraine. Nat. Rev. Neurosci. 4, 386-398 (2003)
5. Tfelt-Hansen, P.C. &Koehler, P.J. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010. Headache 51, 752-778 (2011)
6. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33, 629-808 (2013)
7. Polderman, T.J.C. et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat. Genet. 47, 702-709 (2015)
8. Anttila, V. et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet. 42, 869-873 (2010)
9. Chasman, D.I. et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet. 43, 695-698 (2011)
10. Freilinger, T. et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat. Genet. 44, 777-782 (2012)
11. Anttila, V. et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat. Genet. 45, 912-917 (2013)
12. Ophoff, R.A. et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543-552 (1996)
13. De Fusco, M. et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33, 192-196 (2003)
14. Dichgans, M. et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366, 371-377 (2005)
15. Nyholt, D.R. et al. A high-density association screen of 155 ion transport genes for involvement with common migraine. Hum. Mol. Genet. 17, 3318-3331 (2008)
16. 1000 Genomes Project Consortium et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012)
17. Chasman, D.I. et al. Selectivity in genetic association with sub-classified migraine in women. PLoS Genet. 10, e1004366 (2014)
18. Han, B. &Eskin, E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am. J. Hum. Genet. 88, 586-598 (2011)
19. Morton, M.J., Abohamed, A., Sivaprasadarao, A. &Hunter, M. pH sensing in the two-pore domain K+ channel, TASK2. Proc. Natl. Acad. Sci. USA 102, 16102-16106 (2005)
20. Ramachandran, R. et al. TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc. Natl. Acad. Sci. USA 110, 7476-7481 (2013)
21. Hanna, M.G. Genetic neurological channelopathies. Nat. Clin. Pract. Neurol. 2, 252-263 (2006)
22. Kraev, A. et al. Molecular cloning of a third member of the potassium-dependent sodium-calcium exchanger gene family, NCKX3. J. Biol. Chem. 276, 23161-23172 (2001)
23. Ismailov, I.I. et al. A biologic function for an 'orphan' messenger: D-myo-inositol 3,4,5,6-tetrakisphosphate selectively blocks epithelial calcium-activated chloride channels. Proc. Natl. Acad. Sci. USA 93, 10505-10509 (1996)
24. De Bock, M. et al. Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 31, 1942-1957 (2011)
25. Kathiresan, S. et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334-341 (2009)
26. Debette, S. et al. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. Nat. Genet. 47, 78-83 (2015)
27. Law, C. et al. Clinical features in a family with an R460H mutation in transforming growth factor β receptor 2 gene. J. Med. Genet. 43, 908-916 (2006)
28. Bown, M.J. et al. Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am. J. Hum. Genet. 89, 619-627 (2011)
29. Arndt, A.K. et al. Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am. J. Hum. Genet. 93, 67-77 (2013)
30. Fujimura, M. et al. Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J. Stroke 16, 65-72 (2014)
31. McElhinney, D.B. et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106, 2567-2574 (2002)
32. Bezzina, C.R. et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat. Genet. 45, 1044-1049 (2013)
33. Sinner, M.F. et al. Integrating genetic, transcriptional, and functional analyses to identify five novel genes for atrial fibrillation. Circulation 130, 1225-1235 (2014)
34. Neale, B.M. et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc. Natl. Acad. Sci. USA 107, 7395-7400 (2010)
35. Desch, M. et al. IRAG determines nitric oxide-and atrial natriuretic peptide-mediated smooth muscle relaxation. Cardiovasc. Res. 86, 496-505 (2010)
36. Lang, N.N., Luksha, L., Newby, D.E. &Kublickiene, K. Connexin 43 mediates endothelium-derived hyperpolarizing factor-induced vasodilatation in subcutaneous resistance arteries from healthy pregnant women. Am. J. Physiol. Heart Circ. Physiol. 292, H1026-H1032 (2007)
37. Dong, H., Jiang, Y., Triggle, C.R., Li, X. &Lytton, J. Novel role for K+-dependent Na+/Ca2+ exchangers in regulation of cytoplasmic free Ca2+ and contractility in arterial smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 291, H1226-H1235 (2006)
38. Yamaji, M., Mahmoud, M., Evans, I.M. &Zachary, I.C. Neuropilin 1 is essential for gastrointestinal smooth muscle contractility and motility in aged mice. PLoS One 10, e0115563 (2015)
39. Lu, X. et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat. Genet. 44, 890-894 (2012)
40. Hager, J. et al. Genome-wide association study in a Lebanese cohort confirms PHACTR1 as a major determinant of coronary artery stenosis. PLoS One 7, e38663 (2012)
41. The Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat. Genet. 43, 339-344 (2011)
42. O'Donnell, C.J. et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation 124, 2855-2864 (2011)
43. Porcu, E. et al. A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet. 9, e1003266 (2013)
44. Soler Artigas, M. et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat. Genet. 43, 1082-1090 (2011)
45. Lu, T. et al. REST and stress resistance in ageing and Alzheimer disease. Nature 507, 448-454 (2014)
46. Kar, R., Riquelme, M.A., Werner, S. &Jiang, J.X. Connexin 43 channels protect osteocytes against oxidative stress-induced cell death. J. Bone Miner. Res. 28, 1611-1621 (2013)
47. Dixit, D., Ghildiyal, R., Anto, N.P. &Sen, E. Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism. Cell Death Dis. 5, e1212 (2014)
48. Chuikov, S., Levi, B.P., Smith, M.L. &Morrison, S.J. Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress. Nat. Cell Biol. 12, 999-1006 (2010)
49. Castellano, J. et al. Hypoxia stimulates low-density lipoprotein receptor-related protein-1 expression through hypoxia-inducible factor-1α in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 31, 1411-1420 (2011)
50. Schlossmann, J. et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Iβ. Nature 404, 197-201 (2000)
51. Nalls, M.A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 46, 989-993 (2014)
52. Lambert, J.C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458 (2013)
53. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014)
54. Wood, A.R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173-1186 (2014)
55. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007)
56. Bulik-Sullivan, B.K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291-295 (2015)
57. Yang, J. et al. Genomic inflation factors under polygenic inheritance. Eur. J. Hum. Genet. 19, 807-812 (2011)
58. Magi, R., Lindgren, C.M. &Morris, A.P. Meta-analysis of sex-specific genome-wide association studies. Genet. Epidemiol. 34, 846-853 (2010)
59. Maller, J.B. et al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet. 44, 1294-1301 (2012)
60. Nicolae, D.L. et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6, e1000888 (2010)
61. Maurano, M.T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190-1195 (2012)
62. The GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580-585 (2013)
63. Pers, T.H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015)
64. Chi, J.T. et al. Gene expression programs of human smooth muscle cells: tissue-specific differentiation and prognostic significance in breast cancers. PLoS Genet. 3, 1770-1784 (2007)
65. Bernstein, B.E. et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat. Biotechnol. 28, 1045-1048 (2010)
66. The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012)
67. Winsvold, B.S. et al. Genetic analysis for a shared biological basis between migraine and coronary artery disease. Neurol. Genet. 1, e10 (2015)
68. Malik, R. et al. Shared genetic basis for migraine and ischemic stroke: a genome-wide analysis of common variants. Neurology 84, 2132-2145 (2015)
69. Ferrari, M.D., Klever, R.R., Terwindt, G.M., Ayata, C. &van den Maagdenberg, A.M.J.M. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 14, 65-80 (2015)
70. Olesen, J., Burstein, R., Ashina, M. &Tfelt-Hansen, P. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol. 8, 679-690 (2009)
71. Hadjikhani, N. et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl. Acad. Sci. USA 98, 4687-4692 (2001)
72. Lauritzen, M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 117, 199-210 (1994)
73. Olesen, J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol. Ther. 120, 157-171 (2008)
74. Ashina, M., Hansen, J.M. &Olesen, J. Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience. Cephalalgia 33, 540-553 (2013)
75. Read, S.J. &Parsons, A.A. Sumatriptan modifies cortical free radical release during cortical spreading depression: a novel antimigraine action for sumatriptan? Brain Res. 870, 44-53 (2000)
76. Anderson, C.A. et al. Data quality control in genetic case-control association studies. Nat. Protoc. 5, 1564-1573 (2010)
77. Winkler, T.W. et al. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 9, 1192-1212 (2014)
78. Delaneau, O., Marchini, J. &Zagury, J.-F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179-181 (2011)
79. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. &Abecasis, G.R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012)
80. Browning, S.R. &Browning, B.L. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 81, 1084-1097 (2007)
81. Li, Y., Willer, C.J., Ding, J., Scheet, P. &Abecasis, G.R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816-834 (2010)
82. Fuchsberger, C., Abecasis, G.R. &Hinds, D.A. minimac2: faster genotype imputation. Bioinformatics 31, 782-784 (2015)
83. The International HapMap 3 Consortium. Integrating common and rare genetic variation in diverse human populations. Nature 467, 52-58 (2010)
84. Schwarz, G. Estimating the dimension of a model. Ann. Stat. 6, 461-464 (1978)
85. Wright, F.A. et al. Heritability and genomics of gene expression in peripheral blood. Nat. Genet. 46, 430-437 (2014)
86. Richards, A.L. et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol. Psychiatry 17, 193-201 (2012)
87. Nyholt, D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74, 765-769 (2004)
88. Farh, K.K.-H. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337-343 (2015)
89. Mi, H., Muruganujan, A., Casagrande, J.T. &Thomas, P.D. Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551-1566 (2013)
90. Fehrmann, R.S.N. et al. Gene expression analysis identifies global gene dosage sensitivity in cancer. Nat. Genet. 47, 115-125 (2015)
91. Frey, B.J. &Dueck, D. Clustering by passing messages between data points. Science 315, 972-976 (2007)